Global and United States Varicella Vaccine Market Insights, Forecast to 2027

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.

Market Analysis and Insights: Global and United States Varicella Vaccine Market
This report focuses on global and United States Varicella Vaccine market.
In 2020, the global Varicella Vaccine market size was US$ 3872 million and it is expected to reach US$ 6550.4 million by the end of 2027, with a CAGR of 7.8% during 2021-2027. In United States the Varicella Vaccine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Varicella Vaccine Scope and Market Size
Varicella Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Varicella Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Varicella Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Injection
Freeze-Dried Powder

Segment by Application
Kids Injection
Adults Injection

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken